These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7901927)

  • 1. PCNA/cyclin and P-glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical, retrospective study.
    Botti G; Chiappetta G; D'Aiuto G; de Angelis E; De Matteis A; Montella M; Picone A; Cascione F
    Tumori; 1993 Jun; 79(3):214-8. PubMed ID: 7901927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
    Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
    Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity in breast carcinoma evaluated by BrdU and PCNA. Correlation with expression of p53, c-erbB-2, estrogen receptor and P-glycoprotein.
    Moriki T; Takahashi T; Tanioka F; Yamane T; Hara H
    Pathol Res Pract; 1995 Nov; 191(11):1122-32. PubMed ID: 8822114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between C219 and drug resistance in lung neoplasms].
    Oddi G; De Angelis G; Alma MG; De Marinis F; Bigioni D
    Minerva Med; 1993 Apr; 84(4):179-82. PubMed ID: 8099431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients.
    Bianchi S; Paglierani M; Zampi G; Cardona G; Cataliotti L; Bonardi R; Zappa M; Ciatto S
    Cancer; 1993 Jul; 72(1):120-5. PubMed ID: 8099532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancer.
    Seymour L; Bezwoda WR; Dansey RD
    Breast Cancer Res Treat; 1995; 36(1):61-9. PubMed ID: 7579508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
    Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients.
    Prajoko YW; Aryandono T
    Asian Pac J Cancer Prev; 2019 May; 20(5):1511-1518. PubMed ID: 31128056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
    Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
    Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
    Linn SC; Honkoop AH; Hoekman K; van der Valk P; Pinedo HM; Giaccone G
    Br J Cancer; 1996 Jul; 74(1):63-8. PubMed ID: 8679460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
    Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
    J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables.
    Betta PG; Bottero G; Pavesi M; Pastormerlo M; Bellinger D; Tallarida F
    Surg Oncol; 1993; 2(1):59-63. PubMed ID: 7902763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
    Haerslev T; Jacobsen GK; Zedeler K
    Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
    Aaltomaa S; Lipponen P; Syrjänen K
    Anticancer Res; 1992; 12(4):1281-6. PubMed ID: 1380227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
    Dixon AR; Bell J; Ellis IO; Elston CW; Blamey RW
    Br J Cancer; 1992 Sep; 66(3):537-41. PubMed ID: 1355661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
    J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
    Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R
    Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients.
    Gago FE; Tello OM; Diblasi AM; Ciocca DR
    J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):431-7. PubMed ID: 10030692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.